(CBK) Commerzbank - Ratings and Ratios
Loans, Accounts, Cards, Trade Finance, Asset Management
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.83% |
| Yield on Cost 5y | 13.37% |
| Yield CAGR 5y | 15.02% |
| Payout Consistency | 45.1% |
| Payout Ratio | 28.6% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 30.5% |
| Value at Risk 5%th | 47.1% |
| Relative Tail Risk | -6.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.39 |
| Alpha | 125.25 |
| CAGR/Max DD | 2.30 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.457 |
| Beta | 0.223 |
| Beta Downside | 0.467 |
| Drawdowns 3y | |
|---|---|
| Max DD | 25.68% |
| Mean DD | 8.08% |
| Median DD | 7.15% |
Description: CBK Commerzbank December 04, 2025
Commerzbank AG (XETRA: CBK) is a German-headquartered universal bank that serves private-individuals, small-business owners, corporates, financial-service firms and institutional investors across Europe, the Americas and Asia. Its operations are split into two segments – Private & Small-Business Customers and Corporate Clients – delivering a full suite of retail banking products (savings, checking, credit/debit cards, loans, pension and payment solutions) and corporate services (real-estate financing, M&A advisory, trade finance, securities trading, wealth and asset management).
Key recent metrics indicate the bank is navigating a challenging European banking environment: the CET1 capital ratio stood at roughly 13.5 % at year-end 2023, while the cost-to-income ratio improved to about 65 % after a multi-year efficiency program. Net interest income benefited from the ECB’s rate hikes in 2023-24, lifting the net interest margin by ~15 bps, and loan growth remained modest at ~2 % YoY. A sector-wide driver is the ongoing digital transformation, with Commerzbank reporting a 12 % YoY increase in online transaction volume, which is critical for sustaining fee income as traditional margins tighten.
If you want to dig deeper into how these drivers translate into valuation upside or downside for CBK, a quick look at ValueRay’s analytical dashboards can provide a data-rich perspective.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (2.64b TTM) > 0 and > 6% of Revenue (6% = 1.47b TTM) |
| FCFTA -0.04 (>2.0%) and ΔFCFTA -7.03pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 215.3% (prev 816.5%; Δ -601.2pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.03 (>3.0%) and CFO -18.14b <= Net Income 2.64b (YES >=105%, WARN >=100%) |
| Net Debt (-69.27b) to EBITDA (3.91b) ratio: -17.73 <= 3.0 (WARN <= 3.5) |
| Current Ratio 4.23 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.13b) change vs 12m ago -4.83% (target <= -2.0% for YES) |
| Gross Margin 53.45% (prev 48.17%; Δ 5.29pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 4.24% (prev 4.41%; Δ -0.17pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.25 (EBITDA TTM 3.91b / Interest Expense TTM 11.44b) >= 6 (WARN >= 3) |
Altman Z'' 0.78
| (A) 0.09 = (Total Current Assets 69.27b - Total Current Liabilities 16.38b) / Total Assets 592.95b |
| (B) 0.03 = Retained Earnings (Balance) 19.39b / Total Assets 592.95b |
| (C) 0.00 = EBIT TTM 2.89b / Avg Total Assets 579.14b |
| (D) 0.05 = Book Value of Equity 30.31b / Total Liabilities 561.14b |
| Total Rating: 0.78 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 56.39
| 1. Piotroski 4.50pt |
| 2. FCF Yield 85.76% |
| 3. FCF Margin -87.34% |
| 4. Debt/Equity 0.13 |
| 5. Debt/Ebitda -17.73 |
| 6. ROIC - WACC (= -4.36)% |
| 7. RoE 7.90% |
| 8. Rev. Trend 80.56% |
| 9. EPS Trend 62.78% |
What is the price of CBK shares?
Over the past week, the price has changed by +0.00%, over one month by +3.89%, over three months by +11.54% and over the past year by +132.02%.
Is CBK a buy, sell or hold?
What are the forecasts/targets for the CBK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33.9 | -4.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 56.2 | 58% |
CBK Fundamental Data Overview December 27, 2025
Market Cap EUR = 40.29b (40.29b EUR * 1.0 EUR.EUR)
P/E Trailing = 17.2609
P/E Forward = 12.9702
P/S = 3.5588
P/B = 1.174
P/EG = 1.441
Beta = 0.636
Revenue TTM = 24.57b EUR
EBIT TTM = 2.89b EUR
EBITDA TTM = 3.91b EUR
Long Term Debt = 53.33b EUR (from longTermDebt, last fiscal year)
Short Term Debt = unknown (none)
Debt = 3.96b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -69.27b EUR (from netDebt column, last quarter)
Enterprise Value = -25.03b EUR (40.29b + Debt 3.96b - CCE 69.27b)
Interest Coverage Ratio = 0.25 (Ebit TTM 2.89b / Interest Expense TTM 11.44b)
FCF Yield = 85.76% (FCF TTM -21.46b / Enterprise Value -25.03b)
FCF Margin = -87.34% (FCF TTM -21.46b / Revenue TTM 24.57b)
Net Margin = 10.74% (Net Income TTM 2.64b / Revenue TTM 24.57b)
Gross Margin = 53.45% ((Revenue TTM 24.57b - Cost of Revenue TTM 11.44b) / Revenue TTM)
Gross Margin QoQ = 47.26% (prev 55.18%)
Tobins Q-Ratio = -0.04 (set to none) (Enterprise Value -25.03b / Total Assets 592.95b)
Interest Expense / Debt = 70.38% (Interest Expense 2.79b / Debt 3.96b)
Taxrate = 36.42% (374.0m / 1.03b)
NOPAT = 1.84b (EBIT 2.89b * (1 - 36.42%))
Current Ratio = 4.23 (Total Current Assets 69.27b / Total Current Liabilities 16.38b)
Debt / Equity = 0.13 (Debt 3.96b / totalStockholderEquity, last quarter 30.36b)
Debt / EBITDA = -17.73 (Net Debt -69.27b / EBITDA 3.91b)
Debt / FCF = 3.23 (negative FCF - burning cash) (Net Debt -69.27b / FCF TTM -21.46b)
Total Stockholder Equity = 33.41b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.45% (Net Income 2.64b / Total Assets 592.95b)
RoE = 7.90% (Net Income TTM 2.64b / Total Stockholder Equity 33.41b)
RoCE = 3.33% (EBIT 2.89b / Capital Employed (Equity 33.41b + L.T.Debt 53.33b))
RoIC = 1.87% (NOPAT 1.84b / Invested Capital 97.98b)
WACC = 6.23% (E(40.29b)/V(44.24b) * Re(6.84%) + (debt cost/tax rate unavailable))
Discount Rate = 6.84% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -4.65%
Fair Price DCF = unknown (Cash Flow -21.46b)
EPS Correlation: 62.78 | EPS CAGR: 11.70% | SUE: -0.35 | # QB: 0
Revenue Correlation: 80.56 | Revenue CAGR: 12.15% | SUE: 0.51 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.77 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=3.03 | Chg30d=+0.021 | Revisions Net=+4 | Growth EPS=+22.5% | Growth Revenue=+8.1%